four hundred and thirty-eight patients who had suffered a thromboembolic stroke not less than two weeks or more than four months previously , were entered into a placebo-controlled randomized clinical trial to determine whether suloctidil ( 200 mg t.i.d . ) would influence the subsequent recurrence of stroke , the occurrence of myocardial infarction , or cardiovascular death .
C0027051
myocardial infarction
C0007226
cardiovascular